Hepatic epithelioid angiomyolipoma: a clinicopathologic analysis of 25 cases.
- Author:
Huan XU
1
;
Huan WANG
1
;
Xiuhui ZHANG
1
;
Gandi LI
2
Author Information
- Publication Type:Journal Article
- MeSH: Age Factors; Angiomyolipoma; genetics; immunology; metabolism; pathology; Biomarkers, Tumor; metabolism; Diagnosis, Differential; Female; Follow-Up Studies; Gastrointestinal Neoplasms; Giant Cells; pathology; Humans; Immunohistochemistry; Immunophenotyping; Liver Neoplasms; genetics; immunology; metabolism; pathology; MART-1 Antigen; metabolism; Melanoma-Specific Antigens; metabolism; Muscle, Smooth; metabolism; Prognosis
- From: Chinese Journal of Pathology 2014;43(10):685-689
- CountryChina
- Language:Chinese
-
Abstract:
OBJECTIVETo study the clinicopathologic features, immunophenotype, histological diagnosis and prognosis of hepatic epithelioid angiomyolipoma.
METHODSClinical data of 25 cases of hepatic epithelioid angiomyolipoma were collected along with follow-up study of the patients. The pathological features were documented and immunohistochemical study of various markers was performed with an emphasis on diagnosis and differential diagnosis.
RESULTSHepatic epithelioid angiomyolipoma was more commonly found in young women without characteristic clinical symptoms. Its morphological features were characterized by marked cytological atypia, relatively rare mitotic figures; radial distribution of tumor cells around the thin-walled blood vessels or muscular vessels; and the presence of common multinucleated giant cells and large ganglion-like tumor cells. The tumor cells expressed both melanoma cell markers (HMB45, MART-1) and smooth muscle cell markers (SMA). Tumor cells expressed various other markers including ER 16% (4/25), PR 32% (8/25), TFE3 24% (6/25) and p53 60% (15/25).
CONCLUSIONSHepatic epithelioid angiomyolipoma has variable morphological features and characteristic immunohistochemical phenotype. The differential diagnoses include a variety of tumors. The biological behavior of the tumor tends to be benign.